Affiliations 

  • 1 D. Sinniah, MA, MD, FRACP, DCH. Assoc. Professor, Department of Paediatrics, Faculty of Medicine University of Malaya, Kuala Lumpur, Malaysia
  • 2 W.A. Ariffin, MBBS. Medical Officer, Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 3 H.W. Shiong, MBBS. Medical Otficer, Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 4 H.P. Lin, MSSS, FRACP, MRCP, DCH. Assoc. Professor, Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
Singapore Med J, 1981 Dec;22(6):350-3.
PMID: 6950522

Abstract

A 13 year review at the University Hospital, Kuala Lumpur reveals that chronic myeloid leukaemia (CML) constitutes 4.3% of all childhood leukaemia. Adult type of CML occurs in older children and is associated with marked splenomegaly, leukocytosis and thrombocytosis and the presence of Philadelphia chromosome. Although the initial response to busulphan was encouraging most of the patients succumbed; 2 patients underwent acute lymphoblastic transformation. Juvenile CML occurs in younger children and is associated with less marked splenomegaly, leukocytosis and thrombocytopenia and the presence of elevated fetal haemoglobin levels. The disease is characterised by an acute fulminating course. Despite improved survival in acute lymphoblastic leukaemia, the outlook for chronic myeloid leukaemia in childhood remains poor and treatment needs re-evaluation.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.